Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China · Delayed Price · Currency is CNY 24.35
-0.85 (-3.37%)
Sep 10, 2026, 12:44 PM CST
SHE:002940 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,327 | 1,425 | 1,538 | 1,621 | 1,568 | 1,380 |
Revenue Growth | -6.17% | -7.35% | -5.10% | 3.32% | 13.62% | 7.03% |
Gross Profit Gross Profit Growth | 521.02 | 557.6 | 612.57 | 706.85 | 893.58 | 892.36 |
Operating Income Operating Income Growth | 139.33 | 152.19 | 118.37 | 163.64 | 141.77 | 151.25 |
Net Income Net Income Growth | 114.44 | 125.44 | 80.33 | 138.37 | 127.3 | 119.84 |
Earnings Per Share EPS Growth | 0.56 | 0.62 | 0.40 | 0.69 | 0.64 | 0.60 |
EPS Growth | 43.85% | 55.00% | -42.03% | 7.81% | 6.67% | -30.30% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Preparations Preparations Growth | 677.86 | 546.98 | 649.61 | 933.28 | 973.9 |
Raw Materials Raw Materials Growth | 575.86 | 747.44 | 806.92 | 607.17 | 389.69 |
Specialty Intermediates Specialty Intermediates Growth | 139.94 | 200.1 | 149.68 | - | - |
Others Others Growth | 31.14 | 43.36 | 5.35 | 8.09 | 5.48 |
Total Total Growth | 1,425 | 1,538 | 1,626 | 1,568 | 1,380 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 834.84 | 789.67 | 733.42 | 869.75 | 804.76 | 748.51 |
Total Debt Total Debt Growth | 412.34 | 454.42 | 487.08 | 589.52 | 346.96 | 1.76 |
Net Cash (Debt) Net Cash Growth | 422.5 | 335.25 | 246.34 | 280.23 | 457.8 | 746.75 |
Net Cash Growth | 48.10% | 36.09% | -12.10% | -38.79% | -38.69% | -11.34% |
Net Cash Per Share Net Cash Per Share Growth | 2.07 | 1.66 | 1.23 | 1.40 | 2.30 | 3.74 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 294.62 | 244.13 | 253.6 | 276.91 | 184.75 | 197.65 |
Capital Expenditures CapEx Growth | -57.8 | -49.94 | -94.46 | -124.95 | -68.82 | -87.32 |
Free Cash Flow Free Cash Flow Growth | 236.82 | 194.19 | 159.14 | 151.96 | 115.92 | 110.33 |
Free Cash Flow Growth | 153.96% | 22.02% | 4.72% | 31.09% | 5.07% | 2.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 39.25% | 39.13% | 39.83% | 43.62% | 56.97% | 64.65% |
Operating Margin | 10.50% | 10.68% | 7.70% | 10.10% | 9.04% | 10.96% |
Pretax Margin | 11.95% | 12.65% | 10.30% | 12.79% | 9.37% | 12.51% |
Profit Margin | 8.62% | 8.80% | 5.22% | 8.54% | 8.12% | 8.68% |
FCF Margin | 17.84% | 13.63% | 10.35% | 9.38% | 7.39% | 7.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.300 | 0.250 | 0.125 | 0.210 | 0.207 | 0.143 |
Dividend Per Share Growth | 100.00% | 100.00% | -40.48% | 1.50% | 44.99% | -39.99% |
Dividend Yield | 1.18% | 0.75% | 0.96% | 0.99% | 1.15% | 0.86% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 44.95 | 52.40 | 32.77 | 31.63 | 28.94 | 29.09 |
P/FCF Ratio | 20.87 | 33.85 | 16.54 | 28.80 | 31.78 | 31.59 |
PS Ratio | 3.72 | 4.61 | 1.71 | 2.70 | 2.35 | 2.53 |